Abstract
Atrial Fibrillation Pipeline, Technology and Market Forecasts to 2015
Summary
GlobalData’s medical device report: “Atrial Fibrillation Systems
Pipeline Technology and Market Forecasts to 2015” is an essential source
of information and analysis on the global atrial fibrillation market. The
report identifies the key trends shaping and driving the dynamism in the
global atrial fibrillation market. The report also provides insight on the
prevalent competitive landscape and the emerging players expected to bring
significant shift in the market positioning of the existing market leaders.
The report also analyses the M&A landscape in the global atrial fibrillation
market with special focus on the market participants that have been the most
M&A active. Most importantly, the report provides valuable insight on the
pipeline products within the global atrial fibrillation sector.
Scope
- Annualized global atrial fibrillation market revenues data from 2001 to
2008, forecast forward for 7 years to 2015.
- Analysis and review of the
key events and milestones that will impact the future of the global atrial
fibrillation market. Each trend independently researched to provide
qualitative analysis of what the implications on sectors are, and how are
companies responding to these trends.
- Insightful review of key industry
drivers, restraints and challenges which are likely to impact the global
atrial fibrillation market in the long run.
- In-depth analysis of the M&A
landscape with a strong emphasis on the market players, likely to remain
active in the near future.
- The report also covers information on the
leading market players, the competitive landscape, and the leading pipeline
products and technologies.
- Comprehensive analysis of the most likely
developments expected to bring a shift to the market positions of the leading
manufacturers.
- The report is built using data and information sourced
from proprietary databases, primary and secondary research and in house
analysis by GlobalData’s team of industry experts.
Reasons to buy
- Develop business strategies by understanding the trends shaping and driving
the global atrial fibrillation market.
- Identify key players best
positioned to take advantage of the emerging market opportunities by
developing insight on the prevalent and anticipated competitive landscape.
- Drive revenues by understanding key trends, innovative products and
technologies, market segments and companies likely to impact the global atrial
fibrillation market in future.
- Formulate effective sales and marketing
strategies by understanding the competitive landscape and by analyzing the
performance of various competitors.
- Identify emerging players with
potentially strong product portfolio and create effective counter-strategies
to gain competitive advantage.
- Organize your sales and marketing efforts
by identifying the market categories and segments that present maximum
opportunities for consolidations, investments and strategic partnerships.
- Support your go/non-go dilemma by identifying the markets that are least
competitive and present significant opportunities for innovation and
growth.
- Develop and design your in-licensing and out-licensing
strategies through review of pipeline products and technologies and by
identifying companies with the most robust pipeline.
Keywords
Catheter ablation market, electrophysiology, pipeline products, ablation,
competitive analysis, company share, market share, pipeline products,
drivers, restraints, volume
Table of Contents
1 Table Of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2
Atrial Fibrillation Pipeline Technology and Market Forecasts to 2015 7
2.1
Introductions and Definitions 7
2.1.1 Electrophysiology 7
2.1.1.1
Electrophysiology Ablation Catheter 7
2.1.1.2 Electrophysiology Diagnostic
Catheter 7
2.1.1.3 Electrophysiology Lab Systems 7
2.2 Executive
Summary 8
3 Atrial Fibrillation Technology Landscape 9
3.1 Atrial
Fibrillation: Overview 9
3.2 Atrial Fibrillation Ablation 10
3.3
Atrial Fibrillation Clinical Trials 11
3.3.1 Comparison of ablation to
drug therapy for atrial fibrillation 11
3.3.2 Catheter Ablation Versus
Anti-arrhythmic Drug Therapy for Atrial Fibrillation 12
3.3.3 Study of
Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation 12
3.3.4 Ablation or Surgery for Atrial Fibrillation (AF) Treatment 13
3.3.5
Tailored Treatment of Permanent Atrial Fibrillation 13
3.4 Comparative
Effectiveness Research for Radiofrequency Catheter Ablation of Atrial
Fibrillation 14
4 Global Atrial Fibrillation Ablation Catheters Market
15
4.1 Market Overview 15
4.2 Atrial Fibrillation Ablation Catheters
Cross Country Analysis of Revenue 16
4.3 Atrial Fibrillation Ablation
Catheters Market Trends 17
4.3.1 Atrial Fibrillation Ablation Catheters
Market Drivers 17
4.3.2 Atrial Fibrillation Market Restraints 17
4.4
Atrial Fibrillation Ablation Catheters Emerging Trends 18
5 Global
Electrophysiology Market 19
5.1 Market Overview 19
5.2
Electrophysiology Cross Segment Analysis 21
5.3 Electrophysiology Cross
Country Analysis 23
5.4 Competitive Landscape 25
6 Atrial Fibrillation
Ablation Catheters Pipeline Products 27
6.1 TactiCath 27
6.1.1 Product
Status 27
6.1.2 Product Description 27
6.1.3 Clinical Trial 27
6.2
Pulmonary Vein Ablation Catheter 28
6.2.1 Product Status 28
6.2.2
Product Description 28
6.2.3 Clinical Trial One 28
6.2.4 Clinical
Trial Two 29
6.2.5 Clinical Trial Three 29
6.3 CoolFlex Ablation
Catheter 30
6.3.1 Product Status 30
6.3.2 Product Description 30
6.4 Cryo Balloon Catheter 31
6.4.1 Product Status 31
6.4.2 Product
Description 31
6.5 Multi-Array Ablation Catheter 32
6.5.1 Product
Status 32
6.5.2 Product Description 32
6.5.3 Clinical Trial 33
7
Global Atrial Fibrillation Ablation Catheters Pipeline Product Summary 34
8 Future Outlook 35
9 Appendix 36
9.1 Research Methodology 36
9.2
Coverage 37
9.3 Secondary Research 38
9.4 Primary Research 38
9.5
Models 39
9.6 Forecasts 39
9.7 Expert Panels 39
9.8 GlobalData
Consulting 40
9.9 Contact Us 40
9.10 Disclaimer 40
1.1 List
of Tables
Table 1: Atrial Fibrillation Ablation Catheters, Global, Revenue
($ m), 2001-2015 15
Table 2: Atrial Fibrillation Ablation Catheters Cross
Country Analysis of Revenue, 2008 16
Table 3: Electrophysiology, Global,
Value ($ m), 2001 - 2008 20
Table 4: Electrophysiology, Global, Value ($
m), 2008 - 2015 20
Table 5: Electrophysiology, Global, Cross Segment
Analysis, 2008 21
Table 6: Electrophysiology Cross Country Analysis of
Revenue, 2008 24
Table 7: NAVISTAR-First Ablation Catheter For Atrial
Fibrillation in Market 26
Table 8: TactiCath, Product Status 27
Table 9: TactiCath, Product Description 27
Table 10: TactiCath
Clinical Trial 27
Table 11: Pulmonary Vein Ablation Catheter, Product
Status 28
Table 12: Pulmonary Vein Ablation Catheter, Product
Description 28
Table 13: Pulmonary Vein Ablation Catheter Clinical
Trial One 28
Table 14: Pulmonary Vein Ablation Catheter Clinical
Trial Two 29
Table 15: Pulmonary Vein Ablation Catheter Clinical
Trial Three 29
Table 16: CoolFlex Ablation Catheter, Product Status
30
Table 17: CoolFlex Ablation Catheter, Product Description 30
Table 18: Cryo Balloon Catheter, Product Status 31
Table 19:
Cryo Balloon Catheter, Product Description 31
Table 20: Multi-Array
Ablation Catheter, Product Status 32
Table 21: Multi-Array Ablation
Catheter, Product Description 32
Table 22: Multi-Array Ablation
Catheter Clinical Trial 33
Table 23: Global Atrial Fibrillation Ablation
Catheters Pipeline Product Summary 34
1.2 List of Figures
Figure
1: Heart Rhythm Disorder and Treatment Methods 10
Figure 2: Atrial
Fibrillation Treatment Methodology 10
Figure 3: Atrial Fibrillation
Ablation Catheters, Global, Revenue ($ m), 2001-2015 15
Figure 4: Atrial
Fibrillation Ablation Catheters Cross Country Analysis of Revenue, 2008 16
Figure 5: Electrophysiology, Global, Revenue ($ m), 2001-2015 19
Figure 6:
Electrophysiology, Global, Cross Segment Analysis, 2008 21
Figure 7:
Electrophysiology Cross Country Analysis of Revenue, 2008 23
Figure 8:
Electrophysiology, Company Shares, Global, 2008 25
Figure 9: GlobalData
Methodology 37
| 
